Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and suppor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Isabelle Arnet, Melina Verbeek, Birna Almarsdóttir Anna, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenny Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Biologicals Biosimilars Automatic substitution Interchangeability Pharmacy Community pharmacy Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/60395ed6f9cd467db5386e97aee9c018
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:60395ed6f9cd467db5386e97aee9c018
record_format	dspace
spelling	oai:doaj.org-article:60395ed6f9cd467db5386e97aee9c0182021-11-28T04:40:02ZCommunity pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey2667-276610.1016/j.rcsop.2021.100084https://doaj.org/article/60395ed6f9cd467db5386e97aee9c0182021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667276621000846https://doaj.org/toc/2667-2766Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.Isabelle ArnetMelina VerbeekBirna Almarsdóttir AnnaLiese BarbierRhonda CliffordChristiane EickhoffKurt HersbergerIsabelle HuysKenny LeeKritsanee SaramuneeMartin SchulzDavid ZgarrickKati SarnolaElsevierarticleBiologicalsBiosimilarsAutomatic substitutionInterchangeabilityPharmacyCommunity pharmacyPharmacy and materia medicaRS1-441ENExploratory Research in Clinical and Social Pharmacy, Vol 4, Iss , Pp 100084- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biologicals Biosimilars Automatic substitution Interchangeability Pharmacy Community pharmacy Pharmacy and materia medica RS1-441
spellingShingle	Biologicals Biosimilars Automatic substitution Interchangeability Pharmacy Community pharmacy Pharmacy and materia medica RS1-441 Isabelle Arnet Melina Verbeek Birna Almarsdóttir Anna Liese Barbier Rhonda Clifford Christiane Eickhoff Kurt Hersberger Isabelle Huys Kenny Lee Kritsanee Saramunee Martin Schulz David Zgarrick Kati Sarnola Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
description	Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.
format	article
author	Isabelle Arnet Melina Verbeek Birna Almarsdóttir Anna Liese Barbier Rhonda Clifford Christiane Eickhoff Kurt Hersberger Isabelle Huys Kenny Lee Kritsanee Saramunee Martin Schulz David Zgarrick Kati Sarnola
author_facet	Isabelle Arnet Melina Verbeek Birna Almarsdóttir Anna Liese Barbier Rhonda Clifford Christiane Eickhoff Kurt Hersberger Isabelle Huys Kenny Lee Kritsanee Saramunee Martin Schulz David Zgarrick Kati Sarnola
author_sort	Isabelle Arnet
title	Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
title_short	Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
title_full	Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
title_fullStr	Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
title_full_unstemmed	Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
title_sort	community pharmacists' preparedness for substituting biologics and dispensing biosimilars – lessons learned from a multinational survey
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/60395ed6f9cd467db5386e97aee9c018
work_keys_str_mv	AT isabellearnet communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT melinaverbeek communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT birnaalmarsdottiranna communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT liesebarbier communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT rhondaclifford communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT christianeeickhoff communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT kurthersberger communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT isabellehuys communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT kennylee communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT kritsaneesaramunee communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT martinschulz communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT davidzgarrick communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey AT katisarnola communitypharmacistspreparednessforsubstitutingbiologicsanddispensingbiosimilarslessonslearnedfromamultinationalsurvey
_version_	1718408261163548672

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Ejemplares similares